Afya Limited (NASDAQ:AFYA) to Issue Annual Dividend of $0.66

Afya Limited (NASDAQ:AFYA) announced an annual dividend on Thursday, March 12th, NASDAQ Dividends reports. Stockholders of record on Wednesday, March 25th will be paid a dividend of 0.656 per share on Monday, April 6th. This represents a dividend yield of 460.0%. The ex-dividend date is Wednesday, March 25th.

Afya has a dividend payout ratio of 12.0% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Afya to earn $1.91 per share next year, which means the company should continue to be able to cover its $0.23 annual dividend with an expected future payout ratio of 12.0%.

Afya Stock Performance

NASDAQ AFYA opened at $14.69 on Monday. The business has a 50 day moving average price of $14.34 and a 200 day moving average price of $14.74. The company has a market capitalization of $1.38 billion, a P/E ratio of 10.06, a PEG ratio of 0.66 and a beta of 0.52. Afya has a 1-year low of $13.00 and a 1-year high of $19.90. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.20 and a quick ratio of 0.98.

Afya (NASDAQ:AFYA) last posted its earnings results on Thursday, March 12th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.05. The company had revenue of $147.08 million for the quarter, compared to analyst estimates of $174.74 million. Afya had a return on equity of 18.77% and a net margin of 20.31%. Sell-side analysts expect that Afya will post 1.52 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a research note on Friday, January 16th. Bank of America lowered shares of Afya from a “buy” rating to a “neutral” rating and lowered their price target for the company from $22.00 to $17.00 in a research report on Tuesday, February 24th. UBS Group restated a “neutral” rating and set a $16.00 price objective (down from $18.00) on shares of Afya in a research report on Friday, January 16th. Zacks Research raised Afya from a “strong sell” rating to a “hold” rating in a research note on Monday, March 9th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a report on Wednesday, January 21st. One equities research analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, Afya currently has an average rating of “Hold” and an average price target of $17.30.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.